Literature DB >> 15731049

Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases.

Bernard W Senior1, Jenny M Woof.   

Abstract

Components of the human immunoglobulin A1 (IgA1) hinge governing sensitivity to cleavage by bacterial IgA1 proteases were investigated. Recombinant antibodies with distinct hinge mutations were constructed from a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region. This hybrid antibody and all the mutant antibodies derived from it were resistant to cleavage by the IgA1 proteases from Streptococcus oralis and Streptococcus mitis biovar 1 strains but were cleaved to various degrees by those of Streptococcus pneumoniae, some Streptococcus sanguis strains, and the type 1 and 2 IgA1 proteases of Haemophilus influenzae, Neisseria meningitidis, and Neisseria gonorrhoeae. Remarkably, those proteases that cleave a Pro-Ser peptide bond in the wild-type IgA1 hinge were able to cleave mutant antibodies lacking a Pro-Ser peptide bond in the hinge, and those that cleave a Pro-Thr peptide bond in the wild-type IgA1 hinge were able to cleave mutant antibodies devoid of a Pro-Thr peptide bond in the hinge. Thus, the enzymes can cleave alternatives to their preferred postproline peptide bond when such a bond is unavailable. Peptide sequence analysis of a representative antibody digestion product confirmed this conclusion. The presence of a cleavable peptide bond near the CH2 end of the hinge appeared to result in greater cleavage than if the scissile bond was at the CH1 end of the hinge. Proline-to-serine substitution at residue 230 in a hinge containing potentially cleavable Pro-Ser and Pro-Thr peptide bonds increased the resistance of the antibody to cleavage by many IgA1 proteases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731049      PMCID: PMC1064975          DOI: 10.1128/IAI.73.3.1515-1522.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases.

Authors:  B W Senior; J I Dunlop; M R Batten; M Kilian; J M Woof
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  The Clostridium ramosum IgA proteinase represents a novel type of metalloendopeptidase.

Authors:  Klaudia Kosowska; Jesper Reinholdt; Lone Kjar Rasmussen; Artur Sabat; Jan Potempa; Mogens Kilian; Knud Poulsen
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

3.  IgA protease production as a characteristic distinguishing pathogenic from harmless neisseriaceae.

Authors:  M H Mulks; A G Plaut
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

4.  Cleavage of the hormone human chorionic gonadotropin, by the Type 1 IgA1 protease of Neisseria gonorrhoeae, and its implications.

Authors:  B W Senior; W W Stewart; C Galloway; M A Kerr
Journal:  J Infect Dis       Date:  2001-08-29       Impact factor: 5.226

5.  Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA.

Authors:  Koteswara R Chintalacharuvu; Philip D Chuang; Ashley Dragoman; Christine Z Fernandez; Jiazhou Qiu; Andrew G Plaut; K Ryan Trinh; Françoise A Gala; Sherie L Morrison
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Studies on gonococcus infection. XVII. IgA1-cleaving protease in vaginal washings from women with gonorrhea.

Authors:  M Blake; K K Holmes; J Swanson
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

7.  Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases.

Authors:  Margaret R Batten; Bernard W Senior; Mogens Kilian; Jenny M Woof
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Large-scale identification of virulence genes from Streptococcus pneumoniae.

Authors:  A Polissi; A Pontiggia; G Feger; M Altieri; H Mottl; L Ferrari; D Simon
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A.

Authors:  A G Plaut; J V Gilbert; M S Artenstein; J D Capra
Journal:  Science       Date:  1975-12-12       Impact factor: 47.728

10.  Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease.

Authors:  A G Plaut; R Wistar; J D Capra
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  14 in total

1.  Outsmarting the host: bacteria modulating the immune response.

Authors:  Matthew D Woolard; Jeffrey A Frelinger
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?

Authors:  Randall J Brezski; Robert E Jordan
Journal:  MAbs       Date:  2010-05-23       Impact factor: 5.857

3.  Relaxed cleavage specificity of an immunoglobulin A1 protease from Neisseria meningitidis.

Authors:  Srdjan Vitovski; Jon R Sayers
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

4.  Rabbit IgA Hinges That Resist IgA1 Protease Action Provide Options for Improved IgA-Based Therapeutic Agents.

Authors:  Patrícia de Sousa-Pereira; Dennis K Lanning; Pedro J Esteves; Christian Spoerry; Jenny M Woof; Ana Pinheiro
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  The expression of soluble and active recombinant Haemophilus influenzae IgA1 protease in E. coli.

Authors:  Shinong Long; Elaine Phan; Michel C Vellard
Journal:  J Biomed Biotechnol       Date:  2010-11-30

6.  Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease.

Authors:  Troy A Johnson; Jiazhou Qiu; Andrew G Plaut; Todd Holyoak
Journal:  J Mol Biol       Date:  2009-04-23       Impact factor: 5.469

Review 7.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

8.  A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy.

Authors:  Xuejun Fan; Randall J Brezski; Ming Fa; Hui Deng; Allison Oberholtzer; Anneliese Gonzalez; William P Dubinsky; William R Strohl; Robert E Jordan; Ningyan Zhang; Zhiqiang An
Journal:  Breast Cancer Res       Date:  2012-08-08       Impact factor: 6.466

9.  Computational analyses of an evolutionary arms race between mammalian immunity mediated by immunoglobulin A and its subversion by bacterial pathogens.

Authors:  Ana Pinheiro; Jenny M Woof; Laurent Abi-Rached; Peter Parham; Pedro J Esteves
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

10.  Differentiation of gram-negative bacterial aerosol exposure using detected markers in bronchial-alveolar lavage fluid.

Authors:  David Wunschel; Bobbie-Jo Webb-Robertson; Charles W Frevert; Shawn Skerrett; Nat Beagley; Alan Willse; Heather Colburn; Kathryn Antolick
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.